← back to search

Meiling Piao

Chinese Academy of Sciences · CN
Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include Folate and B Vitamins Research, RNA and protein synthesis mechanisms, RNA Research and Splicing, and Metabolism and Genetic Disorders.
h-index
6
citations
263
works
21
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content
PLoS Biology 2018cited by 63position: middledoi
Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)
Molecular Pharmaceutics 2015cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kathleen M. Giacomini · University of California, San Francisco2 papers (2015–2018)Huan‐Chieh Chien · Amgen (United States)2 papers (2015–2018)Sook Wah Yee · Pfizer (United States)2 papers (2015–2018)Eugene C. Chen · Medical College of Wisconsin2 papers (2015–2018)Jolyn Twelves · Gilead Sciences (United States)1 papers (2015–2015)Arias Mifune · University of California, San Francisco1 papers (2018–2018)Ronald M. Krauss · UCSF Benioff Children's Hospital1 papers (2018–2018)Ling Zou · Bioanalytica (Switzerland)1 papers (2018–2018)Meredith Calvert · Gladstone Institutes1 papers (2018–2018)Hao Jia · Ministry of Industry and Information Technology1 papers (2015–2015)Qi Luo · Guizhou University1 papers (2018–2018)Ligong Chen · Hebei Agricultural University1 papers (2018–2018)Xiaomin Liang · Southwest University1 papers (2015–2015)Eve‐Irene Lepist · Gilead Sciences (United States)1 papers (2015–2015)Marilyn M. Giacomini · Gilead Sciences (United States)1 papers (2015–2015)Janna Abad · Gladstone Institutes1 papers (2018–2018)Xiaomin Liang · Gilead Sciences (United States)1 papers (2018–2018)Frode Norheim · University of Oslo1 papers (2018–2018)Adrian S. Ray · Gilead Sciences (United States)1 papers (2015–2015)Sarah King · University of Queensland1 papers (2018–2018)